Osteoporosis and International normalised ratio abnormal
Summary:
International normalised ratio abnormal is found among people with Osteoporosis, especially for people who are female, 60+ old.
The study analyzes which people have International normalised ratio abnormal with Osteoporosis. It is created by eHealthMe based on reports of 32 people who have Osteoporosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 1,814 drugs and 1,900 conditions by eHealthMe. Check the latest studies of Osteoporosis.
What is International normalised ratio abnormal?
International normalised ratio abnormal is found to be associated with 329 drugs and 472 conditions by eHealthMe. Check the latest studies of International normalised ratio abnormal.
32 people who have Osteoporosis and International Normalised Ratio Abnormal are studied.

Gender of people who have Osteoporosis and experienced International Normalised Ratio Abnormal *:
- female: 96.3 %
- male: 3.7 %
Age of people who have Osteoporosis and experienced International Normalised Ratio Abnormal *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 4.35 %
- 60+: 95.65 %
Common co-existing conditions for these people *:
- Pain: 10 people, 31.25%
- High Blood Pressure: 5 people, 15.62%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 12.50%
- Back Pain: 3 people, 9.38%
- High Blood Cholesterol: 3 people, 9.38%
- Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 2 people, 6.25%
- Asthma: 2 people, 6.25%
- Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 6.25%
- Depression: 2 people, 6.25%
- Gout (uric acid crystals building up in the body): 2 people, 6.25%
Common drugs taken by these people *:
- Coumadin: 13 people, 40.62%
- Forteo: 11 people, 34.38%
- Diclofenac: 9 people, 28.12%
- Celebrex: 9 people, 28.12%
- Fosamax: 5 people, 15.62%
- Vitamin D: 3 people, 9.38%
- Lipitor: 3 people, 9.38%
- Prolia: 3 people, 9.38%
- Pepcid: 3 people, 9.38%
- Vitamin C: 2 people, 6.25%
Common symptoms for these people *:
- Blood Alkaline Phosphatase Increased: 11 people, 34.38%
- Fatigue (feeling of tiredness): 11 people, 34.38%
- Hepatic Necrosis (large portions of liver die off due to severe liver disease): 9 people, 28.12%
- Alanine Aminotransferase Increased: 9 people, 28.12%
- Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 9 people, 28.12%
- Aspartate Aminotransferase Increased: 9 people, 28.12%
- Insomnia (sleeplessness): 7 people, 21.88%
- Head Injury: 5 people, 15.62%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 12.50%
- Injection Site Erythema (redness at injection site): 4 people, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have International normalised ratio abnormal?
- Check whether International normalised ratio abnormal is associated with a drug or a conditionRelated publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Related studies:
Treatments, associated drugs and conditions:
- Osteoporosis (290,734 reports)
- International normalised ratio abnormal (4,071 reports)
All the drugs that are associated with International normalised ratio abnormal:
- International normalised ratio abnormal (329 drugs)
All the conditions that are associated with International normalised ratio abnormal:
- International normalised ratio abnormal (472 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on International normalised ratio abnormal and Osteoporosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Augmentin cause Blood Disorder? - 2 seconds ago
- Could Aricept cause Abulia? - 3 seconds ago
- Drug interactions of Phenytoin and Ultram - 5 seconds ago
- Pituitary-Dependent Cushing'S Syndrome and Memory Loss - 9 seconds ago
- Drug interactions of Zolpidem Tartrate and Fexofenadine Hydrochloride - 18 seconds ago
- Drug interactions of Abilify and Nexplanon - 22 seconds ago
- Chronic Obstructive Pulmonary Disease and Non-Small Cell Lung Cancer Metastatic - 47 seconds ago
- Could Nuplazid cause Movement - Uncoordinated? - 49 seconds ago
- Drug interactions of Klonopin and Luvox Cr - 54 seconds ago
- Pain and X-Ray Abnormal - 57 seconds ago